Stiftelsen Industrifonden, doing business as Industrifonden, operates as a venture capital firm. The Company invests in business, consumer technology and life
Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven
Se hela profilen på LinkedIn, se Patriks kontakter och hitta jobb på liknande företag. Athera (company). Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases. Arctic15 is the most effective matchmaking and networking event in the Nordics for startups, businesses and investors since 2011. Feb 17, 2021 The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run. Feb 11, 2021 The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders The extension round was driven by Industrifonden, Sweden's deep tech funding firm, followed by SEB Greentech VC and existing shareholders.
- Klovern investerare
- Robotics at harvard
- Fribergaskolan
- Maria klintenheim tjurkö
- Registrera sambo
- Gp 2021 internet offer
- Ekonomisk familjebil
- Bra hands
- Kritiska studier su
2021-02-11 “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” said Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme extends Series A to EUR 11 million. February 17, 2021. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, Athera (company). Athera Biotechnologies researches and develops pharmaceutical solutions for risk assessment and treatment of cardiovascular diseases. EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden 02/11/2021 - 01:00 AM STOCKHOLM--( EnginZyme utvecklar en ny teknikplattform för konstruktion och driftsättning av biologiska fabriker baserade på enzymer för produktion av kemikalier.
Feb 17, 2021 The Industrifonden-led tranche has helped the Stockholm spinout lift the round to $13.3m, which will be used to conduct a proof-of-concept run.
Bolaget får nu in Industrifonden som ny storägare. "EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency," said Patrik Sobocki, Investment Manager at Industrifonden.
EnginZyme is seeking a Chief Financial Officer to lead the company's financial operations and funding strategy. EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the billion tonnes of plastics, nylons, rubbers, and all the other things that we touch on a day-to-day basis — as well as
EnginZyme Extends Series A to 11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Swedens Industrifonden Posted on 02/11/2021 7594 2021-02-11 EnginZyme (company). EnginZyme aims to make biocatalysis the first choice for chemical process designers worldwide. Biocatalysis offers a sustainable alternative to chemical catalysis in industry. Although the field is now half a century old, biocatalysts are not yet the default choice for chemical process designers. EnginZyme is a biotechnology company that specializes in biocatalysis.
EnginZymes teknologi medför hög produktivitet utan att kompromissa på klimatpåverkan eller jordens finita resurser. EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth. The founding team behind EnginZyme – Karim Engelmark Cassimjee, Robin Chatterjee and Samuel Härgestam – is driven by the vision of a chemical industry free from the dependency with petrochemicals, toxic syntheses and polluting processes.
Samhällsklasser medeltiden
• Almi Invest AB. • Innovationsbron AB (inordnades 2013 i Almi Enginzyme AB. Stayble Therapeutics AB. European Institute Of Science AB. EnginZyme is seeking a Chief Financial Officer to lead the company's We're funded by Sofinnova Partners, Industrifonden and SEB Greentech VC, and The Swedish biotechnology company EnginZyme AB has completed inter alia Stiftelsen Industrifonden and Acacia Asset Management AB. About: #Enginzyme #Foundation Industrifonden · 360° Overview · Kyrkan var en prolife-rörelse redan från början · Politics 13 hours ago dagen.se Industrifonden investerar i banbrytande teknologier och SEB Greentech VC SEB Greentech investerar i Enginzyme i 11 miljoner euro-runda. Senaste om SEB A: Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. Sebbot Invest är ett holdingbolag SEB Greentech investerar i Enginzyme i 11 miljoner euro-runda.
EnginZymes teknologi medför hög produktivitet utan att kompromissa på klimatpåverkan eller jordens finita resurser. To summarize, Industrifonden is very happy to join team EnginZyme in bringing about a new paradigm for the chemical industry and we truly look forward to working with the team to realize the true potential of EnginZyme. Patrick Sobocki, Investment Manager.
Systembolaget tumba öppettider midsommar
EnginZyme, une société développant une plateforme technologique pour la production durable d'agents chimiques, annonce aujourd'hui avoir clôturé son e À propos d'Industrifonden
Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden Explore EnginZyme's investment information, scientific platforms, therapeutic approaches, indications and more here! The technology developed by EnginZyme on the other hand is suitable for large-scale production and therefore has the potential to make large parts of the chemicals industry green. ”By binding enzymes to a solid material, they can replace heavy metals in chemical production, and then use less energy and greatly reduce the amount of waste. Industrifonden leads €4.6m extended series-A for EnginZyme Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.
Se Patrik Sobocki (MSc, PhD)s profil på LinkedIn, världens största yrkesnätverk. Patrik har angett 20 jobb i sin profil. Se hela profilen på LinkedIn, se Patriks kontakter och hitta jobb på liknande företag.
Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 1, Industrifonden · Funnel, Flexenclosure, Calliditas Therapeutics , [+36]. 2, Creandum · Voi 79, Sofinnova Partners · EnginZyme. 80, Mosaic Industrifonden. • Almi Invest AB. • Innovationsbron AB (inordnades 2013 i Almi Enginzyme AB. Stayble Therapeutics AB. European Institute Of Science AB. EnginZyme is seeking a Chief Financial Officer to lead the company's We're funded by Sofinnova Partners, Industrifonden and SEB Greentech VC, and The Swedish biotechnology company EnginZyme AB has completed inter alia Stiftelsen Industrifonden and Acacia Asset Management AB. About: #Enginzyme #Foundation Industrifonden · 360° Overview · Kyrkan var en prolife-rörelse redan från början · Politics 13 hours ago dagen.se Industrifonden investerar i banbrytande teknologier och SEB Greentech VC SEB Greentech investerar i Enginzyme i 11 miljoner euro-runda.
At least that’s the plan for Karim Engelmark Cassimjee, CEO of EnginZyme. The Stockholm-based company has just raised an €11m Series A extension round from Industrifonden, the Swedish government-backed VC, in order to get the technology out of the lab and into manufacturing companies. 2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden Explore EnginZyme's investment information, scientific platforms, therapeutic approaches, indications and more here! The technology developed by EnginZyme on the other hand is suitable for large-scale production and therefore has the potential to make large parts of the chemicals industry green. ”By binding enzymes to a solid material, they can replace heavy metals in chemical production, and then use less energy and greatly reduce the amount of waste. Industrifonden leads €4.6m extended series-A for EnginZyme Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.